Arjan P Vos

Summary

Affiliation: Danone Vitapole
Country: France

Publications

  1. doi request reprint Specific prebiotic oligosaccharides modulate the early phase of a murine vaccination response
    Arjan P Vos
    Danone Research Centre for Specialised Nutrition, Wageningen, The Netherlands
    Int Immunopharmacol 10:619-25. 2010
  2. ncbi request reprint Dietary supplementation of neutral and acidic oligosaccharides enhances Th1-dependent vaccination responses in mice
    Arjan P Vos
    Department of Biomedical Research, Numico Research, Wageningen, The Netherlands
    Pediatr Allergy Immunol 18:304-12. 2007
  3. ncbi request reprint Impaired immune function: an early marker for cancer cachexia
    Joyce Faber
    Danone Research, Centre for Specialised Nutrition, Wageningen, The Netherlands
    Oncol Rep 22:1403-6. 2009

Detail Information

Publications3

  1. doi request reprint Specific prebiotic oligosaccharides modulate the early phase of a murine vaccination response
    Arjan P Vos
    Danone Research Centre for Specialised Nutrition, Wageningen, The Netherlands
    Int Immunopharmacol 10:619-25. 2010
    ..Furthermore, the results demonstrate that it is critical to consider kinetic aspects of immune-modulatory and prebiotic effects in order to study their interaction in a meaningful way...
  2. ncbi request reprint Dietary supplementation of neutral and acidic oligosaccharides enhances Th1-dependent vaccination responses in mice
    Arjan P Vos
    Department of Biomedical Research, Numico Research, Wageningen, The Netherlands
    Pediatr Allergy Immunol 18:304-12. 2007
    ..As Th1-responses are weak in early life in humans, this might suggest that application of these oligosaccharides in infant formulas will be beneficial for the development of the infant's immune system...
  3. ncbi request reprint Impaired immune function: an early marker for cancer cachexia
    Joyce Faber
    Danone Research, Centre for Specialised Nutrition, Wageningen, The Netherlands
    Oncol Rep 22:1403-6. 2009
    ..Extrapolating to the human setting, reduced immune competence of cancer patients could serve as an early marker for cancer cachexia, enabling an early supportive care strategy...